ScreenerHero
COLO-BColoplast A/S
CPH · DK · Healthcare · Medical Instruments & Supplies · coloplast.com
432.00DKK-0.87%Mkt Cap: 14.31B $P/E: 35.58

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Co…

Industry Peers

Medical Instruments & Supplies
Screen all
ISRG
Intuitive Surgical, Inc.
$142.49BUSDP/E 45.6
EL
EssilorLuxottica Societe anonyme
$80.53BUSDP/E 30.2
BDX
Becton, Dickinson and Company
$51.10BUSDP/E 32.5
MDLN
Medline Inc. Class A Common Stock
$45.62BUSDP/E 42.4
ALC
Alcon AG
$32.71BUSDP/E 55.9
RMD
ResMed Inc.
$33.27BUSDP/E 22.1
WST
West Pharmaceutical Services, Inc.
$24.90BUSDP/E 45.4
DIM
Sartorius Stedim Biotech
$20.62BUSDP/E 64.6
SRT3
Sartorius Aktiengesellschaft
$18.68BUSDP/E 87.6
STMN
Straumann Holding AG
$17.47BUSDP/E 41.6
SRT
Sartorius Aktiengesellschaft
$15.01BUSDP/E 70.4
SOLV
Solventum Corporation
$15.08BUSDP/E 10.8
COO
The Cooper Companies, Inc.
$14.85BUSDP/E 64.5
BAX
Baxter International Inc.
$13.77BUSD
ALGN
Align Technology, Inc.
$11.58BUSDP/E 28.3
RGEN
Repligen Corporation
$9.95BUSDP/E 241.6
AVTR
Avantor, Inc.
$9.44BUSD
ATR
AptarGroup, Inc.
$8.45BUSDP/E 24.0
YPSN
Ypsomed Holding AG
$6.15BUSDP/E 25.1
STVN
Stevanato Group S.p.A.
$6.10BUSDP/E 39.2

Key Statistics

Company
Market Cap14.31B $
Enterprise Value17.66B $
Revenue (TTM)4.08B $
Gross Profit2.66B $
Net Income (TTM)735.83M $
Revenue/Share18.13 USD
Last Price432.00 DKK
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees17.1K
CountryDK
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINUS19624Y2000
Valuation
P/E (Trailing)35.58
P/E (Forward)16.72
PEG1.09
EV/EBITDA14.23
EV/Revenue4.32
P/S3.50
P/B7.64
EPS (TTM)9.35
EPS (Forward)26.06
52W Range
369.7022% of range646.60
52W High646.60 DKK
52W Low369.70 DKK
Profitability
Gross Margin67.59%
Oper. Margin25.69%
EBITDA Margin30.37%
Profit Margin18.69%
ROE28.16%
ROA10.51%
Growth
Revenue Growth2.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF402.87M $
CapEx (TTM)196.05M $
FCF Margin14.99%
FCF Yield4.28%
Net Debt3.37B $
Net Debt/EBITDA2.72
Balance Sheet
Debt/Equity1.26
Current Ratio1.75
Quick Ratio1.01
Book Value/Sh57.04 DKK
Cash/Share4.739 DKK
Dividends
Fwd Div Rate23.00 DKK
Trail. Div Rate0.0000 DKK
Div. Yield5.44%
5Y Avg Yield2.88%
Payout Ratio246.25%
Ex-Div DateMay 18, 2026
Pay Date—
Splits
Last Split5:1
Split DateDec 19, 2012
Analyst Consensus
Rating3.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)462.29 DKK
Upside (mean)+7.0%
Target Range345.00 DKK – 600.00 DKK
DKK345.00+7.0% to meanDKK600.00
# Analysts21
Ownership
Shares Out.207.37M
Float144.57M
Insiders29.79%
Institutions32.58%
Technical
SMA 50404.59 (+6.8%)
SMA 200469.80 (-8.0%)
Beta0.55
S&P 52W Chg19.97%
Avg Vol (30d)291.36K
Avg Vol (10d)200.11K
Technical Indicators
RSI (14)56.0
MACD7.3638
MACD Signal7.9004
MACD Hist.-0.5366
BB Upper451.74 DKK
BB Middle429.22 DKK
BB Lower406.71 DKK
BB Width10.49%
ATR (14)11.75 DKK
Vol Ratio (20d)0.93x